Literature DB >> 18050262

Serotonin transporter polymorphism (5-HTTLPR) association with melancholic depression: a female specific effect?

Bernhard T Baune1, Christa Hohoff, Lena S Mortensen, Jürgen Deckert, Volker Arolt, Katharina Domschke.   

Abstract

Earlier studies yielded inconsistent results on the association between variation in the serotonin transporter (5-HTT) gene and depression, with evidence for a differential effect of the 5-HTTLPR on melancholic versus atypical depression. To further delineate the impact of 5-HTT gene variation on psychopathology in depression, in this analysis the influence of the 5-HTTLPR and the functionally closely related 5-HTT rs25531 was investigated in 340 Caucasian patients with a major depressive episode (DSM-IV) with particular attention to the subtype of depression (melancholic depression versus atypical depression) applying logistic regression models adjusted for age and gender. The homozygous, more active 5-HTTLPR LL genotype was significantly associated with melancholic depression (odds ratio, OR, 1.7; 95% confidence interval, CI, 1.1-2.6; P=0.04), with the effect originating in the female subgroup of patients (OR 1.9; 95%CI 1.0-3.4; P=0.05). Also, the more active 5-HTTLPR/5-HTT rs25531 haplotype L(A)L(A) conveyed a significant risk for melancholic depression (OR 2.0; 95%CI 1.3-3.1; P=0.001), again only in the female subsample of patients (OR 2.1; 95%CI 1.1-4.1; P=0.02). The present results provide further support for an association of genetic variation increasing serotonin transporter activity with the melancholic subtype of depression as well as evidence for a potential female-specific mechanism underlying this effect. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18050262     DOI: 10.1002/da.20433

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  12 in total

1.  Blushing propensity in social anxiety disorder: influence of serotonin transporter gene variation.

Authors:  Katharina Domschke; Stephan Stevens; Beate Beck; Anna Baffa; Christa Hohoff; Jürgen Deckert; Alexander L Gerlach
Journal:  J Neural Transm (Vienna)       Date:  2008-07-16       Impact factor: 3.575

2.  Pharmacogenetics of antidepressive treatment.

Authors:  Astrid Zobel; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-01-03       Impact factor: 5.270

Review 3.  Sex differences modulating serotonergic polymorphisms implicated in the mechanistic pathways of risk for depression and related disorders.

Authors:  LeeAnn M Perry; Andrea N Goldstein-Piekarski; Leanne M Williams
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

4.  Serotonin transporter gene methylation is associated with hippocampal gray matter volume.

Authors:  Udo Dannlowski; Harald Kugel; Ronny Redlich; Adriane Halik; Ilona Schneider; Nils Opel; Dominik Grotegerd; Kathrin Schwarte; Christiane Schettler; Oliver Ambrée; Stephan Rust; Katharina Domschke; Volker Arolt; Walter Heindel; Bernhard T Baune; Thomas Suslow; Weiqi Zhang; Christa Hohoff
Journal:  Hum Brain Mapp       Date:  2014-05-23       Impact factor: 5.038

Review 5.  Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.

Authors:  Azmeraw T Amare; Klaus Oliver Schubert; Bernhard T Baune
Journal:  EPMA J       Date:  2017-09-05       Impact factor: 6.543

6.  Can developmental changes in inhibition and peer relationships explain why depressive symptoms increase in early adolescence?

Authors:  Katharine Ann Buck; Theodore Dix
Journal:  J Youth Adolesc       Date:  2011-03-17

7.  Influence of 5-HTT variation, childhood trauma and self-efficacy on anxiety traits: a gene-environment-coping interaction study.

Authors:  Miriam A Schiele; Christiane Ziegler; Karoline Holitschke; Christoph Schartner; Brigitte Schmidt; Heike Weber; Andreas Reif; Marcel Romanos; Paul Pauli; Peter Zwanzger; Jürgen Deckert; Katharina Domschke
Journal:  J Neural Transm (Vienna)       Date:  2016-05-04       Impact factor: 3.575

Review 8.  Clinical and molecular genetics of psychotic depression.

Authors:  Katharina Domschke
Journal:  Schizophr Bull       Date:  2013-03-19       Impact factor: 9.306

9.  Genetic Role of BDNF Val66Met and 5-HTTLPR Polymorphisms on Depressive Disorder.

Authors:  Kyu Young Lee; Seong Hoon Jeong; Se Hyun Kim; Yong Min Ahn; Yong Sik Kim; Hee Yeon Jung; Yang Weon Bang; Eun-Jeong Joo
Journal:  Psychiatry Investig       Date:  2014-04-11       Impact factor: 2.505

10.  Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder.

Authors:  Azmeraw T Amare; Klaus Oliver Schubert; Fasil Tekola-Ayele; Yi-Hsiang Hsu; Katrin Sangkuhl; Gregory Jenkins; Ryan M Whaley; Poulami Barman; Anthony Batzler; Russ B Altman; Volker Arolt; Jürgen Brockmöller; Chia-Hui Chen; Katharina Domschke; Daniel K Hall-Flavin; Chen-Jee Hong; Ari Illi; Yuan Ji; Olli Kampman; Toshihiko Kinoshita; Esa Leinonen; Ying-Jay Liou; Taisei Mushiroda; Shinpei Nonen; Michelle K Skime; Liewei Wang; Masaki Kato; Yu-Li Liu; Verayuth Praphanphoj; Julia C Stingl; William V Bobo; Shih-Jen Tsai; Michiaki Kubo; Teri E Klein; Richard M Weinshilboum; Joanna M Biernacka; Bernhard T Baune
Journal:  Front Psychiatry       Date:  2018-03-06       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.